CLAREMONT, Calif., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCQB:KWBT) (“Kiwa” or the “Company”) is pleased to announce that Japanese Chuon Co., LTD (the “Chuon Company”) visited Kiwa Bio-Tech (Beijing) Co., LTD in Beijing recently to discuss the role of biotechnology in agriculture and advanced methods of controlling “desert”-ification. Desertification is the process by which fertile land becomes desert, typically as a result of drought, deforestation, or inappropriate agriculture.
“In recent years we have witnessed a robust development in China’s bio-fertilizer industry. There is a strong trend towards developing health and safety in soil and agricultural products,” stated Mr. Osawa Kunio, the CEO of Chuon Company. Mr. Osawa applauded the Chinese government’s commitment to soil protection. He also suggested that, as a rapidly growing enterprise with sixteen-years of experience in developing and marketing bio-fertilizers, Kiwa has great potential to become one of the leading bio-fertilizer enterprises in China. Chuon Company has expressed a desire to share its experience with Kiwa regarding biotechnology and soil recovery.
Mr. Song Yong Lin, Kiwa’s CTO and Technical director stated that “Japan is an eco-friendly country, which prioritizes environmental protection and has a mature system of soil remediation. Japan has great experience in biotechnological application and education, which Kiwa can deploy in its own markets.” Japan enjoys a forest coverage rate of up to 67%, which is higher than many other developed countries. Considering the similar geography and climates of China and Japan, Kiwa wishes to follow Japan’s successful experience in soil and apply it to the anti-“desert”-ification project of the China Foundation for Desertification Control. Kiwa believes that these efforts by China represent a multi-billion dollar revenue opportunity.
Both companies agreed to integrate each other’s microbial technologies and establish a practical framework to enhance international awareness. Kiwa is excited about this opportunity as it opens a new business vertical for the Company – their traditional agricultural business will now be paired with a soil preservation division that will be driven by Government policy and budget. This development will help drive growth and facilitate the use of Kiwa’s recently acquired production capacity. Kiwa believes that the first revenues that can be generated from this initiative will be in the second quarter of 2017.
About Chuon Co., LTD.
Chuon Co., LTD. was established in April 1956, located in Matsuyama, Ehime Prefecture, Japan. Chuon Company currently has offices in Beijing and Shanghai China. Since 1989, Chuon has owned its own manufacturing facility named Tsuyoshi in Matsuyama. Over the past decades, Chuon has focused on the fields of microbial technology, manufacturing and processing of agricultural foods and companies with many patents.
About Chinese Desertification Control Foundation (CFDC)
The foundation helps combat desertification in China. Conservation International Mission is to conserve the earth's biodiversity.
About Kiwa Bio-Tech Products Group Corporation
We develop, manufacture, distribute and market innovative, cost-effective and eco-friendly bio-technological products for agriculture. Our main product groups are bio-fertilizer and biologically enhanced livestock feed. Our products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. Our businesses include bio-fertilizer and bio-enhanced feed.
Kiwa’s strategy is to implement increased visibility for marketing Kiwa’s current bio-fertilizer products, together with the development of a “green agriculture” safe food platform in China. Our goal is to build market penetration for our Kiwa brand in China’s trillion dollar “green” agricultural produce market.
For more information on Kiwa and its products, please refer to the Company’s website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission, available for free at www.sec.gov.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.
Last updated on: 25/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.